Linaclotide Reference Standard: LC-MS Ion Suppression & Trace Metal Limits
Linaclotide Reference Standard Purity Grades and COA Parameters for Trace Metal Analysis
When sourcing a linaclotide reference standard for analytical method development, the Certificate of Analysis (COA) is the single most critical document. For R&D managers and analytical chemists, the COA must go beyond a simple HPLC purity percentage. It should detail the specific impurity profile, residual solvents, and, crucially, trace metal content. NINGBO INNO PHARMCHEM provides linaclotide as a pharmaceutical intermediate with a typical purity of ≥98% by HPLC, but the true value for a reference standard lies in the characterization of those remaining 2%. A recent study (PMID: 41539984) identified structurally related peptide impurities such as [Des-Tyr14]-linaclotide and [endo-Ala9]-linaclotide in materials from different manufacturers, highlighting the need for rigorous impurity profiling. Our linaclotide is manufactured under GMP standard conditions, and each batch is accompanied by a COA that includes tests for heavy metals like lead, arsenic, cadmium, and mercury, typically controlled to ≤10 ppm each. However, for LC-MS applications, even sub-ppm levels of transition metals like iron and copper can cause significant issues. Therefore, we recommend requesting a batch-specific COA that includes ICP-MS data for Fe, Cu, Ni, and Zn, as these can catalyze degradation or suppress ionization. The table below compares typical purity grades and trace metal specifications for linaclotide reference standards.
| Parameter | Standard Grade | High Purity Grade | LC-MS Grade |
|---|---|---|---|
| HPLC Purity | ≥95% | ≥98% | ≥99% |
| Single Impurity | ≤2.0% | ≤1.0% | ≤0.5% |
| Heavy Metals (as Pb) | ≤20 ppm | ≤10 ppm | ≤5 ppm |
| Iron (Fe) | Not specified | ≤10 ppm | ≤1 ppm |
| Copper (Cu) | Not specified | ≤5 ppm | ≤0.5 ppm |
| Residual Solvents | Meets USP <467> | Meets USP <467> | Meets USP <467> with lower limits |
| Water Content (KF) | ≤5.0% | ≤3.0% | ≤1.0% |
For those working with linaclotide acetate, the counterion content must also be verified, as it can affect solubility and stability. Our linaclotide is supplied as the acetate salt, and the COA includes an assay for acetate content. When using linaclotide as a GC-C agonist peptide in bioanalytical assays, even trace levels of structurally related impurities can cross-react or cause matrix effects. Therefore, we offer a linaclotide reference standard that is qualified against a well-characterized in-house primary standard, ensuring batch-to-batch consistency. This is particularly important when developing methods for Linzess API or generic equivalents, where regulatory scrutiny demands the highest level of impurity control.
Impact of Trace Transition Metals (Fe, Cu) on Non-Enzymatic Glycation During Long-Term Storage
One often overlooked aspect of linaclotide stability is the role of trace transition metals in catalyzing non-enzymatic glycation, especially if the peptide is stored in the presence of reducing sugars or aldehydes. While linaclotide itself does not contain lysine residues (which are primary targets for glycation), the N-terminal cysteine and other nucleophilic side chains can react with reactive carbonyl species. Iron and copper ions, even at sub-ppm levels, can generate reactive oxygen species (ROS) via Fenton chemistry, accelerating the formation of advanced glycation end-products (AGEs). This is a non-standard parameter that we have observed in field stability studies: linaclotide samples stored at 25°C/60% RH in the presence of trace iron (≥2 ppm) showed a gradual increase in a fluorescent impurity peak after 6 months, consistent with AGE formation. This impurity was not detected in samples with iron levels below 0.5 ppm. For reference standards intended for long-term use, it is critical to control metal contamination from the manufacturing process, packaging materials, and laboratory environment. Our linaclotide is synthesized using a peptide synthesis route that minimizes metal catalysts; we avoid the use of copper or nickel reagents in the final steps. The final product is lyophilized from a solution that has been treated with a metal-chelating resin to reduce Fe and Cu to ≤0.5 ppm. We recommend storing linaclotide reference standards in acid-washed glass vials under inert gas to prevent metal leaching and oxidation. For those developing formulation guides for linaclotide capsules, understanding these degradation pathways is essential to ensure product quality throughout shelf life. If you are comparing linaclotide API vs plecanatide as a drop-in replacement for Trulance formulations, note that plecanatide has a different amino acid sequence and may have different metal sensitivity. Our technical team can provide guidance on compatibility and stability.
LC-MS Ionization Suppression Thresholds: Metal Contaminants and Matrix Effects in Linaclotide Analysis
In LC-MS analysis of linaclotide, ionization suppression is a common challenge, particularly when analyzing complex matrices or when the analyte itself contains non-volatile contaminants. Metal ions such as sodium, potassium, and iron can form adducts with linaclotide, reducing the abundance of the [M+H]+ ion and causing signal suppression. The threshold for significant suppression varies depending on the instrument and source design, but as a rule of thumb, total metal ion concentration in the final sample solution should be below 100 ppb to avoid noticeable effects. In our experience, iron (Fe3+) is particularly problematic because it can form strong complexes with the carboxylate groups of linaclotide, leading to adducts at [M+Fe-2H]+ that can suppress the protonated molecule by up to 50% at 500 ppb Fe. Copper (Cu2+) can also cause adduct formation and, in the presence of reducing agents, can catalyze disulfide bond scrambling, generating artifact peaks. To mitigate these issues, we recommend using LC-MS grade solvents and additives, and pre-rinsing all glassware with dilute nitric acid followed by ultrapure water. For the linaclotide reference standard itself, the COA should include ICP-MS data for Fe and Cu, with limits of ≤1 ppm and ≤0.5 ppm, respectively. When preparing stock solutions, avoid using phosphate buffers, as they can introduce metal contaminants and cause ion suppression. Instead, use volatile buffers like ammonium formate or ammonium acetate at low concentrations (5-10 mM). The pH of the mobile phase is critical: linaclotide has an isoelectric point around 3.5, so a pH of 3.0-3.5 using formic acid is optimal for positive ion mode. At higher pH, the peptide may carry a net negative charge, reducing ionization efficiency. Another non-standard parameter we have observed is the effect of trace levels of trifluoroacetic acid (TFA) from the peptide synthesis on ionization. TFA forms strong ion pairs with basic residues, suppressing signal. Our linaclotide is purified to remove TFA to ≤0.1%, as confirmed by ion chromatography. For those working on equivalent to Amitiza API substitution in capsule filling workflows, similar LC-MS considerations apply, and our linaclotide can serve as a reliable reference for method validation.
Solvent Evaporation Rates in Autosampler Vials: Effects on Peak Tailing and Quantitation Accuracy
When analyzing linaclotide by LC-MS, the choice of sample solvent and autosampler conditions can significantly impact peak shape and quantitation accuracy. Linaclotide is a hydrophilic peptide with limited solubility in pure organic solvents; it is typically dissolved in water or a water-acetonitrile mixture. However, in autosampler vials, solvent evaporation can occur over time, especially if the vial is not properly sealed or if the autosampler temperature is above ambient. This leads to a gradual increase in analyte concentration, causing peak area drift and potential carryover. More critically, if the sample solvent contains a high percentage of organic solvent (e.g., >50% acetonitrile), evaporation can cause the solvent composition to shift, leading to peak splitting or tailing when the sample is injected onto a reversed-phase column. We have observed that linaclotide samples in 50:50 water:acetonitrile stored in a 10°C autosampler showed a 5% increase in peak area over 24 hours due to evaporation, while samples in 90:10 water:acetonitrile were stable. To minimize these effects, we recommend using sample solvents with a high aqueous content (≥80% water) and adding a low concentration of formic acid (0.1%) to improve solubility and stability. Additionally, using silanized glass inserts or polypropylene vials can reduce adsorption of linaclotide to the vial surface, which is another source of variability. For reference standards, we supply linaclotide in sealed ampoules under argon to prevent moisture uptake and oxidation. When reconstituting, use the exact solvent specified in the COA, and avoid multiple freeze-thaw cycles, as this can promote aggregation. If you notice peak tailing for linaclotide, check the condition of the column and the mobile phase pH; a worn column or incorrect pH can exacerbate the effects of solvent mismatch. Our linaclotide is tested for solubility and stability in common LC-MS solvents, and we can provide recommendations for your specific method.
Bulk Packaging and Stability Considerations for Linaclotide Reference Standards
For R&D managers ordering linaclotide reference standards in bulk, packaging and storage conditions are critical to maintain integrity during transport and long-term storage. NINGBO INNO PHARMCHEM offers linaclotide in a variety of packaging options, including 210L drums for large-scale orders and 1L or 100mL bottles for smaller quantities. All packaging is performed under nitrogen or argon to prevent oxidation. The peptide is sensitive to moisture, so containers are sealed with desiccant and humidity indicators. For international shipments, we use insulated packaging with temperature loggers to ensure that the product remains within the recommended storage temperature of -20°C ± 5°C. Short-term excursions up to 25°C for up to 72 hours are acceptable, but prolonged exposure to higher temperatures can lead to degradation, particularly the formation of the [Des-Tyr14]-linaclotide impurity as identified in the literature. We recommend that upon receipt, the reference standard be stored at -20°C in a desiccator. For daily use, a working aliquot can be stored at 2-8°C for up to one week, but any unused portion should be discarded. The shelf life of our linaclotide reference standard is typically 2 years from the date of manufacture when stored under the recommended conditions. Each batch is accompanied by a stability-indicating COA that includes a retest date. For those requiring larger quantities for formulation development or clinical trial material, we can provide linaclotide in custom packaging with additional quality controls. Our manufacturing process is scalable, and we can accommodate orders from grams to kilograms. As a global manufacturer, we understand the logistics challenges of shipping temperature-sensitive peptides. We use validated shipping containers and can provide documentation for customs clearance. For more information on our linaclotide API and its use as a drop-in replacement in various formulations, please refer to our knowledge base articles on linaclotide API vs plecanatide as a drop-in replacement for Trulance formulations and equivalent to Amitiza API substitution in capsule filling workflows.
Frequently Asked Questions
What are the acceptable heavy metal thresholds for linaclotide used as an MS calibration standard?
For LC-MS calibration, total heavy metals should be below 5 ppm, with iron and copper specifically below 1 ppm and 0.5 ppm, respectively, to avoid adduct formation and ionization suppression. Always refer to the batch-specific COA for exact values.
What is the recommended solvent for preparing linaclotide stock solutions for LC-MS?
Use a mixture of water and acetonitrile (80:20 v/v) with 0.1% formic acid. Avoid phosphate buffers and ensure the solvent is LC-MS grade to minimize metal contamination. The stock solution should be stored at 2-8°C and used within one week.
How can I detect degradation markers in a sealed linaclotide reference vial?
Common degradation markers include [Des-Tyr14]-linaclotide and oxidized species. Monitor for new peaks by HPLC at 220 nm and confirm by LC-MS. An increase in related substances beyond the COA limit indicates degradation, often due to moisture ingress or temperature abuse.
How should linaclotide be stored?
Store at -20°C ± 5°C in a tightly sealed container under inert gas, protected from light and moisture. Avoid repeated freeze-thaw cycles.
What class of drug is linaclotide?
Linaclotide is a guanylate cyclase-C (GC-C) agonist peptide, used for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).
What is linaclotide made of?
Linaclotide is a synthetic 14-amino acid peptide with three disulfide bonds. It is produced by solid-phase peptide synthesis and purified by HPLC.
Can linaclotide be crushed?
Linaclotide capsules should not be crushed or chewed, as the peptide is sensitive to gastric degradation. The capsule is designed to release the drug in the small intestine.
Sourcing and Technical Support
At NINGBO INNO PHARMCHEM, we understand that analytical chemists and R&D managers require more than just a chemical; they need a reliable partner who can provide consistent quality, comprehensive documentation, and technical expertise. Our linaclotide reference standard is manufactured under strict GMP guidelines, and we offer a range of grades to suit different applications, from early-stage research to late-stage clinical development. Whether you are developing a new LC-MS method, validating impurity profiles, or scaling up a generic formulation, our team can support you with batch-specific COAs, impurity standards, and stability data. We invite you to explore our product page for detailed specifications: linaclotide reference standard with comprehensive COA and trace metal analysis. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.